Publicaciones en las que colabora con JUAN ANTONIO MOLINA FONT (10)

1998

  1. Melatonin's role as an anticonvulsant and neuronal protector: Experimental and clinical evidence

    Journal of Child Neurology, Vol. 13, Núm. 10, pp. 501-509

  2. Pharmacokinetic characteristics of phenobarbital in hyperbilirubinemic neonates

    Prenatal and Neonatal Medicine, Vol. 3, Núm. 4, pp. 410-416

1997

  1. Efecto de la melatonina como anticonvulsivante y protector neuronal

    Revista de Neurologia, Vol. 25, Núm. 144, pp. 1229-1234

  2. Utility of high doses of melatonin as adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: Two years' experience

    Journal of Pineal Research, Vol. 23, Núm. 2, pp. 97-105

1996

  1. Lipoproteins in pregnant women before and during delivery: Influence on neonatal haemorheology

    Journal of Clinical Pathology, Vol. 49, Núm. 2, pp. 120-123

1995

  1. EVALUACION DE LA ERITHROPOYETINA EN CORDON UMBILICAL: IMPORTANCIA DE LA EDAD GESTACIONAL Y REOLOGIA SANGUINEA

    Anales Espanoles de Pediatria, Vol. 43, Núm. 5, pp. 355-360

  2. Relationship of blood rheology to lipoprotein profile during normal pregnancies and those with intrauterine growth retardation

    Journal of Clinical Pathology, Vol. 48, Núm. 6, pp. 571-574

1994

  1. ANALISIS COMPARATIVO DE LA VISCOSIDAD PLASMATICA DURANTE LA GESTACION Y PERIODO FETO-NATAL: CONTRIBUCION DE LAS FRACCIONES PROTEICAS

    Anales Espanoles de Pediatria, Vol. 41, Núm. 3, pp. 187-189

1993

  1. Absence of plasma melatonin circadian rhythm during the first 72 hours of life in human infants

    Journal of Clinical Endocrinology and Metabolism, Vol. 77, Núm. 3, pp. 699-703

  2. Light deprivation increases plasma levels of melatonin during the first 72 h of life in human infants

    Acta Endocrinologica, Vol. 129, Núm. 5, pp. 442-445